707 related articles for article (PubMed ID: 33169637)
1. Central involvement of SARS-CoV-2 may aggravate ARDS and hypertension.
Cure E; Cumhur Cure M; Vatansev H
J Renin Angiotensin Aldosterone Syst; 2020; 21(4):1470320320972015. PubMed ID: 33169637
[No Abstract] [Full Text] [Related]
2. [The RAAS and SARS-CoV-2: A riddle to solve].
Choi M; Aiello EA; Ennis IL; Villa-Abrille MC
Hipertens Riesgo Vasc; 2020; 37(4):169-175. PubMed ID: 32527699
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 and hypertension.
Kulkarni S; Jenner BL; Wilkinson I
J Renin Angiotensin Aldosterone Syst; 2020; 21(2):1470320320927851. PubMed ID: 32431227
[No Abstract] [Full Text] [Related]
4. Relationship Between ACE2 and Other Components of the Renin-Angiotensin System.
Cohen JB; Hanff TC; Bress AP; South AM
Curr Hypertens Rep; 2020 Jun; 22(7):44. PubMed ID: 32591908
[TBL] [Abstract][Full Text] [Related]
5. How does SARS-CoV-2 cause COVID-19?
Matheson NJ; Lehner PJ
Science; 2020 Jul; 369(6503):510-511. PubMed ID: 32732413
[No Abstract] [Full Text] [Related]
6. Why is SARS-CoV-2 infection milder among children?
Palmeira P; Barbuto JAM; Silva CAA; Carneiro-Sampaio M
Clinics (Sao Paulo); 2020; 75():e1947. PubMed ID: 32428111
[No Abstract] [Full Text] [Related]
7. More evidence is urgently needed to confirm the relation between angiotensin-converting enzyme inhibitors and COVID-19.
Yang S; Meng G
J Mol Cell Cardiol; 2020 Apr; 141():110-111. PubMed ID: 32272142
[No Abstract] [Full Text] [Related]
8. Direct SARS-CoV-2 infection of the heart potentiates the cardiovascular sequelae of COVID-19.
Bose RJC; McCarthy JR
Drug Discov Today; 2020 Sep; 25(9):1559-1560. PubMed ID: 32592868
[No Abstract] [Full Text] [Related]
9. A mouse model for SARS-CoV-2 infection by exogenous delivery of hACE2 using alphavirus replicon particles.
Zhang YN; Li XD; Zhang ZR; Zhang HQ; Li N; Liu J; Li JQ; Zhang HJ; Wang ZJ; Shen S; Shi ZL; Wei HP; Yuan ZM; Ye HQ; Zhang B
Cell Res; 2020 Nov; 30(11):1046-1048. PubMed ID: 32843719
[No Abstract] [Full Text] [Related]
10. Effects of SARS-CoV-2 and its functional receptor ACE2 on the cardiovascular system.
Li M; Chen S; Xiang X; Wang Q; Liu X
Herz; 2020 Nov; 45(7):659-662. PubMed ID: 33025029
[TBL] [Abstract][Full Text] [Related]
11. The ACE-2 in COVID-19: Foe or Friend?
Dalan R; Bornstein SR; El-Armouche A; Rodionov RN; Markov A; Wielockx B; Beuschlein F; Boehm BO
Horm Metab Res; 2020 May; 52(5):257-263. PubMed ID: 32340044
[TBL] [Abstract][Full Text] [Related]
12. Coronavirus disease 2019 and the cardiovascular system: Impacts and implications.
Gupta MD; Girish MP; Yadav G; Shankar A; Yadav R
Indian Heart J; 2020; 72(1):1-6. PubMed ID: 32423554
[No Abstract] [Full Text] [Related]
13. Covid-19 and the Renin Angiotensin System: Implications for the Older Adults.
Bahat G
J Nutr Health Aging; 2020; 24(7):699-704. PubMed ID: 32744564
[No Abstract] [Full Text] [Related]
14. COVID-19 and the liver.
Jothimani D; Venugopal R; Abedin MF; Kaliamoorthy I; Rela M
J Hepatol; 2020 Nov; 73(5):1231-1240. PubMed ID: 32553666
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular disease, heart failure and COVID-19.
Faconti L; Chowienczyk PJ; Shah AM
J Renin Angiotensin Aldosterone Syst; 2020; 21(2):1470320320926903. PubMed ID: 32434431
[No Abstract] [Full Text] [Related]
16. The mechanism and treatment of gastrointestinal symptoms in patients with COVID-19.
Ye Q; Wang B; Zhang T; Xu J; Shang S
Am J Physiol Gastrointest Liver Physiol; 2020 Aug; 319(2):G245-G252. PubMed ID: 32639848
[TBL] [Abstract][Full Text] [Related]
17. Current data on the cardiovascular effects of COVID-19.
Vlachakis PK; Tentolouris A; Tousoulis D; Tentolouris N
Hellenic J Cardiol; 2020; 61(1):46-48. PubMed ID: 32315757
[No Abstract] [Full Text] [Related]
18. Amiodarone in the COVID-19 Era: Treatment for Symptomatic Patients Only, or Drug to Prevent Infection?
Sanchis-Gomar F; Lavie CJ; Morin DP; Perez-Quilis C; Laukkanen JA; Perez MV
Am J Cardiovasc Drugs; 2020 Oct; 20(5):413-418. PubMed ID: 32737841
[TBL] [Abstract][Full Text] [Related]
19. Lifestyle and severe SARS-CoV-2 infections: Does the individual metabolic burden determines the outcome?
Markus B; Kreutz J; Schieffer B
J Renin Angiotensin Aldosterone Syst; 2020; 21(4):1470320320963929. PubMed ID: 33040679
[No Abstract] [Full Text] [Related]
20. Metabolic Syndrome and COVID 19: Endocrine-Immune-Vascular Interactions Shapes Clinical Course.
Bansal R; Gubbi S; Muniyappa R
Endocrinology; 2020 Oct; 161(10):. PubMed ID: 32603424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
